enGene Holdings Future Growth
Future criteria checks 0/6
enGene Holdings is forecast to grow earnings and revenue by 10.8% and 59.2% per annum respectively. EPS is expected to grow by 27.6% per annum. Return on equity is forecast to be -45.4% in 3 years.
Key information
10.8%
Earnings growth rate
27.6%
EPS growth rate
| Biotechs earnings growth | 28.5% |
| Revenue growth rate | 59.2% |
| Future return on equity | -45.4% |
| Analyst coverage | Low |
| Last updated | 18 Nov 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 10/31/2027 | 28 | -87 | N/A | N/A | 3 |
| 10/31/2026 | 4 | -102 | N/A | N/A | 4 |
| 10/31/2025 | N/A | -77 | N/A | N/A | 4 |
| 10/31/2024 | N/A | -58 | N/A | N/A | 5 |
| 7/31/2024 | N/A | -123 | -36 | -35 | N/A |
| 4/30/2024 | N/A | -115 | -37 | -36 | N/A |
| 1/31/2024 | N/A | -107 | -27 | -26 | N/A |
| 10/31/2023 | N/A | -105 | -25 | -25 | N/A |
| 7/31/2023 | N/A | -31 | -24 | -23 | N/A |
| 10/31/2022 | N/A | -29 | -18 | -18 | N/A |
| 10/31/2021 | N/A | -22 | -16 | -16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ENGN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ENGN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ENGN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ENGN is forecast to have no revenue next year.
High Growth Revenue: ENGN is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ENGN is forecast to be unprofitable in 3 years.